Cargando…
Metabolic Effect of Estrogen Receptor Agonists on Breast Cancer Cells in the Presence or Absence of Carbonic Anhydrase Inhibitors
Metabolic shift is one of the major hallmarks of cancer development. Estrogen receptor (ER) activity has a profound effect on breast cancer cell growth through a number of metabolic changes driven by its effect on transcription of several enzymes, including carbonic anhydrases, Stearoyl-CoA desatura...
Autores principales: | Belkaid, Anissa, Čuperlović-Culf, Miroslava, Touaibia, Mohamed, Ouellette, Rodney J., Surette, Marc E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931547/ https://www.ncbi.nlm.nih.gov/pubmed/27240414 http://dx.doi.org/10.3390/metabo6020016 |
Ejemplares similares
-
Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide
por: Cuperlovic-Culf, Miroslava, et al.
Publicado: (2014) -
17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells
por: Belkaid, Anissa, et al.
Publicado: (2015) -
Leveraging Metabolomics to Assess the Next Generation of Temozolomide-based Therapeutic Approaches for Glioblastomas
por: St-Coeur, Patrick-Denis, et al.
Publicado: (2013) -
Machine Learning Methods for Analysis of Metabolic Data and Metabolic Pathway Modeling
por: Cuperlovic-Culf, Miroslava
Publicado: (2018) -
Database of resistance related metabolites in Wheat Fusarium head blight Disease (MWFD)
por: Surendra, Anuradha, et al.
Publicado: (2017)